Drug development - Clinical study

= Special COVID-19 = Coronavirus SARS-CoV2 Drug development - Clinical study

Service description

Implementation of a regulatory clinical phase for a new drug or repositioning for COVID-19: Phase I for toxicity, Phase IIa or IIb, measurement of efficacy and toxicity on a larger cohort, collection of PK/PD pharmacodynamic data.

Materials to provide

Further details on the project may be requested directly by the expert. You will be able to exchange directly with the experts after filling in the form below.

Delivrable(s)

  • Study following the specifications validated with the Expert

Your project

Please answer all questions below to specify your requirements